Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Dec 1, 2021
What’s worst about omicron so far is the uncertainty
How should the world respond to omicron? We just have to wait as there is information that we don't yet have. And for many, the waiting itself is the problem.
Japan Times
COMMENTARY / World
Nov 30, 2021
Omicron is the price we pay for vaccine inequality
Amsterdam's main airport went into lockdown recently after 61 passengers on two flights from southern Africa tested positive for the new virus. Japan, Hong Kong and Israel have also reported cases.
Japan Times
COMMENTARY / World
Nov 29, 2021
COVID-19 has changed socialized medicine in Britain forever
How did the U.K. make it through the past 20 months of COVID-19? The private sector's role in delivering publicly funded care needs to be acknowledged.
Japan Times
WORLD / Science & Health
Nov 28, 2021
Moderna says new vaccine for omicron may be ready in early 2022
Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.
Japan Times
COMMENTARY / World
Nov 28, 2021
Can vaccines get rid of long COVID?
The subject of long COVID has also been divisive, with social media full of both support groups and skeptics.
Japan Times
WORLD
Nov 27, 2021
Merck says its antiviral pill is less effective in final analysis
A final analysis of a clinical trial said the antiviral pill reduced the risk of hospitalization and death among high-risk COVID patients by 30%, down from an earlier estimate of 50%.
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
COMMENTARY / World
Nov 24, 2021
Mass COVID-19 testing: Does it save lives?
Would Japan have seen far greater fatalities if it opted for mass COVID-19 testing like other countries rather than just targeting vulnerable group as it did?
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
JAPAN
Nov 13, 2021
COVID cases in Tokyo hit 471,000 as of March — quadruple official tally — study says
Researchers say asymptomatic or mild cases likely behind dramatic undercount in number of coronavirus infections.
Japan Times
COMMENTARY / World
Nov 12, 2021
Why COVID-19 misinformation works
Misinformed people, especially about COVID-19, do not simply have inaccurate information; they are heavily invested in their misconceptions.
Japan Times
WORLD
Nov 9, 2021
Regeneron antibody prevents COVID-19 infections for eight months
The company has asked the U.S. Food and Drug Administration to expand the authorization so the drug can be used to prevent infections.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
COMMENTARY / World
Nov 7, 2021
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn't be timelier as hospitals face massive backlogs of delayed procedures.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
COMMENTARY / World
Nov 5, 2021
Lessons ASEAN could learn from Malaysia’s pandemic success
Malaysia has fully vaccinated more than 77% its population, with some 90% of adults — those deemed eligible for the vaccine — receiving a second dose.

Longform

A store clerk tries to cool things down in front of their shop by spraying a hose.
Is extreme weather changing the way Japan shops?